SCHEMBL29965355

SCHEMBL29965355

CN(C)Cc1cc(-c2cc(-c3cc(F)c4c(c3)CCNC4=O)c(N)nc2F)ccc1N1CCOCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.36
PDE3B Q13370 4/20 0.35
PDE3A Q14432 4/20 0.35
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDR P35968 1/20 0.32
SYK P43405 1/20 0.32
MTOR P42345 2/20 0.32
F10 P00742 2/20 0.32
ACVRL1 P37023 1/20 0.32
F2 P00734 1/20 0.32
AOC3 Q16853 1/20 0.31
LRRK2 Q5S007 1/20 0.31
ALOX5AP P20292 1/20 0.31
FEN1 P39748 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
JAK2 O60674 1/20 0.31
TYK2 P29597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29964826 0.91 MAPK1 (0.45) MAPK1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL31079206 0.90 PDE3B (0.43) MAPK1PDE3BPDE3AKDRSYK
SCHEMBL31079026 0.88 PDE3B (0.38) MAPK1PDE3BPDE3AF10F2
SCHEMBL29163317 0.88 PDE3B (0.37) MAPK1PDE3BPDE3AKDRSYK
SCHEMBL31079254 0.87 MAPK1 (0.36) MAPK1PDE3BPDE3ACYP1A2CYP3A4
SCHEMBL29964417 0.86 MAPK1 (0.44) MAPK1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL31079168 0.85 MAPK1 (0.43) MAPK1PDE3BPDE3ACYP1A2CYP3A4
SCHEMBL31079155 0.85 XDH (0.41) MAPK1PDE3BPDE3ACYP3A4TYK2
SCHEMBL31079138 0.83 MAPK1 (0.42) MAPK1MTOR
SCHEMBL31079333 0.83 MAPK1 (0.44) MAPK1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPK1 141/4885PDE3B 2870/4885PDE3A 2532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.